News
October 7, 2008
Medelis Expands Worldwide CRO Services with New European Division
Phoenix, AZ - Medelis, Inc., a contract research organization providing complete oncology clinical trial design, management and execution, today announced the formation of Medelis Europe and the appointment of Deirdre Tessman, Ph.D. as its Managing Director. Medelis Europe offers complete oncology drug development services from preclinical through phase III.
Dr. Tessman brings more than 30 years of worldwide drug development and regulatory experience to the Medelis organization. She has directed all phases of pharmaceutical development from research through drug approval and marketing with additional expertise in the startup and turnaround of pharmaceutical companies.
"We are excited to make this significant step in expanding our geographical coverage and our service offerings to our worldwide clients who wish to bring their drugs to the European community for approval and sale," said Medelis CEO Bob Bosserman.
"Dr. Tessman has a long-term relationship with Medelis, and we're delighted to make it official," he continued. "Deirdre has an excellent track record and established reputation for founding and holding senior positions within both CROs and pharmaceutical companies. She is the clear choice to lead our firm's European office and will be a substantial asset for our U.S. and European clients as well as for Medelis' continuing evolution as a worldwide leader in oncology drug development."
Medelis, Inc. is an oncology contract research organization providing a total solution for biotechnology and pharmaceutical companies seeking rapid drug development and approval. Medelis' medical founders, team physicians and clinical trial management physicians, including Dan Von Hoff, James Gourzis and Michael Gordon, are internationally-recognized oncology thought and opinion leaders who understand the future of personalized medicine and threshold of credibility trials. Offerings include strategic plans for regulatory approval from phase I through final approval and complete oncology clinical trial design, management and execution.
####
W Squared provides retained human resources services to Medelis.